The global market for Piroxicam Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Piroxicam capsule is a nonsteroidal anti-inflammatory drug (NSAID) mainly used to relieve pain and inflammation caused by various factors. Its main ingredient is Piroxicam, a drug that selectively inhibits cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). It is commonly used to treat arthritis, osteoarthritis, rheumatoid arthritis and other conditions.

North American market for Piroxicam Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Piroxicam Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Piroxicam Capsules include SK Chemical, Pfizer, AdvaCare Pharma, Elikem Pharmaceuticals, DevLife, Nouvasant Group, Teva Pharmaceuticals USA, Baiyunshan, Chongqing Kerui Pharmaceutical, Guangdong Xinfeng Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Piroxicam Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piroxicam Capsules.

The Piroxicam Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Piroxicam Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Piroxicam Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Piroxicam Capsules Market Report

Report Metric	Details
Report Name	Piroxicam Capsules Market
Segment by Type	Regular Release Modified Release
Segment by Application	Hospital Clinic Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	SK Chemical, Pfizer, AdvaCare Pharma, Elikem Pharmaceuticals, DevLife, Nouvasant Group, Teva Pharmaceuticals USA, Baiyunshan, Chongqing Kerui Pharmaceutical, Guangdong Xinfeng Pharmaceutical, Guangdong Zhongsheng Pharmaceutical, Guangzhou Ouhua Pharmaceutica, Guangdong Pidi Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Piroxicam Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Piroxicam Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Piroxicam Capsules Market report?

Ans: The main players in the Piroxicam Capsules Market are SK Chemical, Pfizer, AdvaCare Pharma, Elikem Pharmaceuticals, DevLife, Nouvasant Group, Teva Pharmaceuticals USA, Baiyunshan, Chongqing Kerui Pharmaceutical, Guangdong Xinfeng Pharmaceutical, Guangdong Zhongsheng Pharmaceutical, Guangzhou Ouhua Pharmaceutica, Guangdong Pidi Pharmaceutical

What are the Application segmentation covered in the Piroxicam Capsules Market report?

Ans: The Applications covered in the Piroxicam Capsules Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Piroxicam Capsules Market report?

Ans: The Types covered in the Piroxicam Capsules Market report are Regular Release, Modified Release

1 Piroxicam Capsules Market Overview

1.1 Product Definition

1.2 Piroxicam Capsules by Type

1.2.1 Global Piroxicam Capsules Market Value Comparison by Type (2024 VS 2031)

1.2.2 Regular Release

1.2.3 Modified Release

1.3 Piroxicam Capsules by Application

1.3.1 Global Piroxicam Capsules Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Pharmacy

1.4 Global Piroxicam Capsules Market Size Estimates and Forecasts

1.4.1 Global Piroxicam Capsules Revenue 2020-2031

1.4.2 Global Piroxicam Capsules Sales 2020-2031

1.4.3 Global Piroxicam Capsules Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Piroxicam Capsules Market Competition by Manufacturers

2.1 Global Piroxicam Capsules Sales Market Share by Manufacturers (2020-2025)

2.2 Global Piroxicam Capsules Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Piroxicam Capsules Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Piroxicam Capsules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Piroxicam Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Piroxicam Capsules, Product Type & Application

2.7 Global Key Manufacturers of Piroxicam Capsules, Date of Enter into This Industry

2.8 Global Piroxicam Capsules Market Competitive Situation and Trends

2.8.1 Global Piroxicam Capsules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Piroxicam Capsules Players Market Share by Revenue

2.8.3 Global Piroxicam Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Piroxicam Capsules Market Scenario by Region

3.1 Global Piroxicam Capsules Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Piroxicam Capsules Sales by Region: 2020-2031

3.2.1 Global Piroxicam Capsules Sales by Region: 2020-2025

3.2.2 Global Piroxicam Capsules Sales by Region: 2026-2031

3.3 Global Piroxicam Capsules Revenue by Region: 2020-2031

3.3.1 Global Piroxicam Capsules Revenue by Region: 2020-2025

3.3.2 Global Piroxicam Capsules Revenue by Region: 2026-2031

3.4 North America Piroxicam Capsules Market Facts & Figures by Country

3.4.1 North America Piroxicam Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Piroxicam Capsules Sales by Country (2020-2031)

3.4.3 North America Piroxicam Capsules Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Piroxicam Capsules Market Facts & Figures by Country

3.5.1 Europe Piroxicam Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Piroxicam Capsules Sales by Country (2020-2031)

3.5.3 Europe Piroxicam Capsules Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Piroxicam Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Piroxicam Capsules Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Piroxicam Capsules Sales by Region (2020-2031)

3.6.3 Asia Pacific Piroxicam Capsules Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Piroxicam Capsules Market Facts & Figures by Country

3.7.1 Latin America Piroxicam Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Piroxicam Capsules Sales by Country (2020-2031)

3.7.3 Latin America Piroxicam Capsules Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Piroxicam Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Piroxicam Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Piroxicam Capsules Sales by Country (2020-2031)

3.8.3 Middle East and Africa Piroxicam Capsules Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Piroxicam Capsules Sales by Type (2020-2031)

4.1.1 Global Piroxicam Capsules Sales by Type (2020-2025)

4.1.2 Global Piroxicam Capsules Sales by Type (2026-2031)

4.1.3 Global Piroxicam Capsules Sales Market Share by Type (2020-2031)

4.2 Global Piroxicam Capsules Revenue by Type (2020-2031)

4.2.1 Global Piroxicam Capsules Revenue by Type (2020-2025)

4.2.2 Global Piroxicam Capsules Revenue by Type (2026-2031)

4.2.3 Global Piroxicam Capsules Revenue Market Share by Type (2020-2031)

4.3 Global Piroxicam Capsules Price by Type (2020-2031)

5 Segment by Application

5.1 Global Piroxicam Capsules Sales by Application (2020-2031)

5.1.1 Global Piroxicam Capsules Sales by Application (2020-2025)

5.1.2 Global Piroxicam Capsules Sales by Application (2026-2031)

5.1.3 Global Piroxicam Capsules Sales Market Share by Application (2020-2031)

5.2 Global Piroxicam Capsules Revenue by Application (2020-2031)

5.2.1 Global Piroxicam Capsules Revenue by Application (2020-2025)

5.2.2 Global Piroxicam Capsules Revenue by Application (2026-2031)

5.2.3 Global Piroxicam Capsules Revenue Market Share by Application (2020-2031)

5.3 Global Piroxicam Capsules Price by Application (2020-2031)

6 Key Companies Profiled

6.1 SK Chemical

6.1.1 SK Chemical Company Information

6.1.2 SK Chemical Description and Business Overview

6.1.3 SK Chemical Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.1.4 SK Chemical Piroxicam Capsules Product Portfolio

6.1.5 SK Chemical Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Pfizer Piroxicam Capsules Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 AdvaCare Pharma

6.3.1 AdvaCare Pharma Company Information

6.3.2 AdvaCare Pharma Description and Business Overview

6.3.3 AdvaCare Pharma Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AdvaCare Pharma Piroxicam Capsules Product Portfolio

6.3.5 AdvaCare Pharma Recent Developments/Updates

6.4 Elikem Pharmaceuticals

6.4.1 Elikem Pharmaceuticals Company Information

6.4.2 Elikem Pharmaceuticals Description and Business Overview

6.4.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio

6.4.5 Elikem Pharmaceuticals Recent Developments/Updates

6.5 DevLife

6.5.1 DevLife Company Information

6.5.2 DevLife Description and Business Overview

6.5.3 DevLife Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.5.4 DevLife Piroxicam Capsules Product Portfolio

6.5.5 DevLife Recent Developments/Updates

6.6 Nouvasant Group

6.6.1 Nouvasant Group Company Information

6.6.2 Nouvasant Group Description and Business Overview

6.6.3 Nouvasant Group Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Nouvasant Group Piroxicam Capsules Product Portfolio

6.6.5 Nouvasant Group Recent Developments/Updates

6.7 Teva Pharmaceuticals USA

6.7.1 Teva Pharmaceuticals USA Company Information

6.7.2 Teva Pharmaceuticals USA Description and Business Overview

6.7.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio

6.7.5 Teva Pharmaceuticals USA Recent Developments/Updates

6.8 Baiyunshan

6.8.1 Baiyunshan Company Information

6.8.2 Baiyunshan Description and Business Overview

6.8.3 Baiyunshan Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Baiyunshan Piroxicam Capsules Product Portfolio

6.8.5 Baiyunshan Recent Developments/Updates

6.9 Chongqing Kerui Pharmaceutical

6.9.1 Chongqing Kerui Pharmaceutical Company Information

6.9.2 Chongqing Kerui Pharmaceutical Description and Business Overview

6.9.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio

6.9.5 Chongqing Kerui Pharmaceutical Recent Developments/Updates

6.10 Guangdong Xinfeng Pharmaceutical

6.10.1 Guangdong Xinfeng Pharmaceutical Company Information

6.10.2 Guangdong Xinfeng Pharmaceutical Description and Business Overview

6.10.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio

6.10.5 Guangdong Xinfeng Pharmaceutical Recent Developments/Updates

6.11 Guangdong Zhongsheng Pharmaceutical

6.11.1 Guangdong Zhongsheng Pharmaceutical Company Information

6.11.2 Guangdong Zhongsheng Pharmaceutical Description and Business Overview

6.11.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio

6.11.5 Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates

6.12 Guangzhou Ouhua Pharmaceutica

6.12.1 Guangzhou Ouhua Pharmaceutica Company Information

6.12.2 Guangzhou Ouhua Pharmaceutica Description and Business Overview

6.12.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio

6.12.5 Guangzhou Ouhua Pharmaceutica Recent Developments/Updates

6.13 Guangdong Pidi Pharmaceutical

6.13.1 Guangdong Pidi Pharmaceutical Company Information

6.13.2 Guangdong Pidi Pharmaceutical Description and Business Overview

6.13.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio

6.13.5 Guangdong Pidi Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Piroxicam Capsules Industry Chain Analysis

7.2 Piroxicam Capsules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Piroxicam Capsules Production Mode & Process Analysis

7.4 Piroxicam Capsules Sales and Marketing

7.4.1 Piroxicam Capsules Sales Channels

7.4.2 Piroxicam Capsules Distributors

7.5 Piroxicam Capsules Customer Analysis

8 Piroxicam Capsules Market Dynamics

8.1 Piroxicam Capsules Industry Trends

8.2 Piroxicam Capsules Market Drivers

8.3 Piroxicam Capsules Market Challenges

8.4 Piroxicam Capsules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

SK Chemical

Pfizer Inc

Advacare Pharma

Teva Pharmaceuticals USA

Baiyunshan

Chongqing Kerui Pharmaceutical

Guangdong Zhongsheng Pharmaceutical

Guangdong Pidi Pharmaceutical

Elikem Pharmaceuticals

DevLife

Nouvasant Group

Guangdong Xinfeng Pharmaceutical

Guangzhou Ouhua Pharmaceutica

List of Tables

Table 1. Global Piroxicam Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Piroxicam Capsules Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Piroxicam Capsules Market Competitive Situation by Manufacturers in 2024

Table 4. Global Piroxicam Capsules Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Piroxicam Capsules Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Piroxicam Capsules Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Piroxicam Capsules Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Piroxicam Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Piroxicam Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Piroxicam Capsules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Piroxicam Capsules, Product Type & Application

Table 12. Global Key Manufacturers of Piroxicam Capsules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Piroxicam Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam Capsules as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Piroxicam Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Piroxicam Capsules Sales by Region (2020-2025) & (K Units)

Table 18. Global Piroxicam Capsules Sales Market Share by Region (2020-2025)

Table 19. Global Piroxicam Capsules Sales by Region (2026-2031) & (K Units)

Table 20. Global Piroxicam Capsules Sales Market Share by Region (2026-2031)

Table 21. Global Piroxicam Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Piroxicam Capsules Revenue Market Share by Region (2020-2025)

Table 23. Global Piroxicam Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Piroxicam Capsules Revenue Market Share by Region (2026-2031)

Table 25. North America Piroxicam Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Piroxicam Capsules Sales by Country (2020-2025) & (K Units)

Table 27. North America Piroxicam Capsules Sales by Country (2026-2031) & (K Units)

Table 28. North America Piroxicam Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Piroxicam Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Piroxicam Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Piroxicam Capsules Sales by Country (2020-2025) & (K Units)

Table 32. Europe Piroxicam Capsules Sales by Country (2026-2031) & (K Units)

Table 33. Europe Piroxicam Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Piroxicam Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Piroxicam Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Piroxicam Capsules Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Piroxicam Capsules Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Piroxicam Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Piroxicam Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Piroxicam Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Piroxicam Capsules Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Piroxicam Capsules Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Piroxicam Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Piroxicam Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Piroxicam Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Piroxicam Capsules Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Piroxicam Capsules Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Piroxicam Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Piroxicam Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Piroxicam Capsules Sales (K Units) by Type (2020-2025)

Table 51. Global Piroxicam Capsules Sales (K Units) by Type (2026-2031)

Table 52. Global Piroxicam Capsules Sales Market Share by Type (2020-2025)

Table 53. Global Piroxicam Capsules Sales Market Share by Type (2026-2031)

Table 54. Global Piroxicam Capsules Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Piroxicam Capsules Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Piroxicam Capsules Revenue Market Share by Type (2020-2025)

Table 57. Global Piroxicam Capsules Revenue Market Share by Type (2026-2031)

Table 58. Global Piroxicam Capsules Price (US$/Unit) by Type (2020-2025)

Table 59. Global Piroxicam Capsules Price (US$/Unit) by Type (2026-2031)

Table 60. Global Piroxicam Capsules Sales (K Units) by Application (2020-2025)

Table 61. Global Piroxicam Capsules Sales (K Units) by Application (2026-2031)

Table 62. Global Piroxicam Capsules Sales Market Share by Application (2020-2025)

Table 63. Global Piroxicam Capsules Sales Market Share by Application (2026-2031)

Table 64. Global Piroxicam Capsules Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Piroxicam Capsules Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Piroxicam Capsules Revenue Market Share by Application (2020-2025)

Table 67. Global Piroxicam Capsules Revenue Market Share by Application (2026-2031)

Table 68. Global Piroxicam Capsules Price (US$/Unit) by Application (2020-2025)

Table 69. Global Piroxicam Capsules Price (US$/Unit) by Application (2026-2031)

Table 70. SK Chemical Company Information

Table 71. SK Chemical Description and Business Overview

Table 72. SK Chemical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. SK Chemical Piroxicam Capsules Product

Table 74. SK Chemical Recent Developments/Updates

Table 75. Pfizer Company Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Pfizer Piroxicam Capsules Product

Table 79. Pfizer Recent Developments/Updates

Table 80. AdvaCare Pharma Company Information

Table 81. AdvaCare Pharma Description and Business Overview

Table 82. AdvaCare Pharma Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. AdvaCare Pharma Piroxicam Capsules Product

Table 84. AdvaCare Pharma Recent Developments/Updates

Table 85. Elikem Pharmaceuticals Company Information

Table 86. Elikem Pharmaceuticals Description and Business Overview

Table 87. Elikem Pharmaceuticals Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Elikem Pharmaceuticals Piroxicam Capsules Product

Table 89. Elikem Pharmaceuticals Recent Developments/Updates

Table 90. DevLife Company Information

Table 91. DevLife Description and Business Overview

Table 92. DevLife Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. DevLife Piroxicam Capsules Product

Table 94. DevLife Recent Developments/Updates

Table 95. Nouvasant Group Company Information

Table 96. Nouvasant Group Description and Business Overview

Table 97. Nouvasant Group Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Nouvasant Group Piroxicam Capsules Product

Table 99. Nouvasant Group Recent Developments/Updates

Table 100. Teva Pharmaceuticals USA Company Information

Table 101. Teva Pharmaceuticals USA Description and Business Overview

Table 102. Teva Pharmaceuticals USA Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Teva Pharmaceuticals USA Piroxicam Capsules Product

Table 104. Teva Pharmaceuticals USA Recent Developments/Updates

Table 105. Baiyunshan Company Information

Table 106. Baiyunshan Description and Business Overview

Table 107. Baiyunshan Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Baiyunshan Piroxicam Capsules Product

Table 109. Baiyunshan Recent Developments/Updates

Table 110. Chongqing Kerui Pharmaceutical Company Information

Table 111. Chongqing Kerui Pharmaceutical Description and Business Overview

Table 112. Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Chongqing Kerui Pharmaceutical Piroxicam Capsules Product

Table 114. Chongqing Kerui Pharmaceutical Recent Developments/Updates

Table 115. Guangdong Xinfeng Pharmaceutical Company Information

Table 116. Guangdong Xinfeng Pharmaceutical Description and Business Overview

Table 117. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product

Table 119. Guangdong Xinfeng Pharmaceutical Recent Developments/Updates

Table 120. Guangdong Zhongsheng Pharmaceutical Company Information

Table 121. Guangdong Zhongsheng Pharmaceutical Description and Business Overview

Table 122. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product

Table 124. Guangdong Zhongsheng Pharmaceutical Recent Developments/Updates

Table 125. Guangzhou Ouhua Pharmaceutica Company Information

Table 126. Guangzhou Ouhua Pharmaceutica Description and Business Overview

Table 127. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product

Table 129. Guangzhou Ouhua Pharmaceutica Recent Developments/Updates

Table 130. Guangdong Pidi Pharmaceutical Company Information

Table 131. Guangdong Pidi Pharmaceutical Description and Business Overview

Table 132. Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Guangdong Pidi Pharmaceutical Piroxicam Capsules Product

Table 134. Guangdong Pidi Pharmaceutical Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Piroxicam Capsules Distributors List

Table 138. Piroxicam Capsules Customers List

Table 139. Piroxicam Capsules Market Trends

Table 140. Piroxicam Capsules Market Drivers

Table 141. Piroxicam Capsules Market Challenges

Table 142. Piroxicam Capsules Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Piroxicam Capsules

Figure 2. Global Piroxicam Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Piroxicam Capsules Market Share by Type: 2024 & 2031

Figure 4. Regular Release Product Picture

Figure 5. Modified Release Product Picture

Figure 6. Global Piroxicam Capsules Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Piroxicam Capsules Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Pharmacy

Figure 11. Global Piroxicam Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Piroxicam Capsules Market Size (2020-2031) & (US$ Million)

Figure 13. Global Piroxicam Capsules Sales (2020-2031) & (K Units)

Figure 14. Global Piroxicam Capsules Average Price (US$/Unit) & (2020-2031)

Figure 15. Piroxicam Capsules Report Years Considered

Figure 16. Piroxicam Capsules Sales Share by Manufacturers in 2024

Figure 17. Global Piroxicam Capsules Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Piroxicam Capsules Players: Market Share by Revenue in Piroxicam Capsules in 2024

Figure 19. Piroxicam Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Piroxicam Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Piroxicam Capsules Sales Market Share by Country (2020-2031)

Figure 22. North America Piroxicam Capsules Revenue Market Share by Country (2020-2031)

Figure 23. United States Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Piroxicam Capsules Sales Market Share by Country (2020-2031)

Figure 26. Europe Piroxicam Capsules Revenue Market Share by Country (2020-2031)

Figure 27. Germany Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Piroxicam Capsules Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Piroxicam Capsules Revenue Market Share by Region (2020-2031)

Figure 34. China Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Piroxicam Capsules Sales Market Share by Country (2020-2031)

Figure 42. Latin America Piroxicam Capsules Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Piroxicam Capsules Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Piroxicam Capsules Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Piroxicam Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Piroxicam Capsules by Type (2020-2031)

Figure 53. Global Revenue Market Share of Piroxicam Capsules by Type (2020-2031)

Figure 54. Global Piroxicam Capsules Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Piroxicam Capsules by Application (2020-2031)

Figure 56. Global Revenue Market Share of Piroxicam Capsules by Application (2020-2031)

Figure 57. Global Piroxicam Capsules Price (US$/Unit) by Application (2020-2031)

Figure 58. Piroxicam Capsules Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions